|
2025-04-15 |
2025-04-14 |
PS
Planned sale
|
Akinsanya Karen
President of R&D, Therapeutics
Officer
|
3,345
-17.6%
25.00
USD 83,625
|
3,345
-17.6%
|
25.00
|
USD 83,625
|
|
|
2025-04-15 |
2025-04-14 |
PS
Planned sale
|
Akinsanya Karen
President of R&D, Therapeutics
Officer
|
5,000
-20.9%
25.11
USD 125,555
|
5,000
-20.9%
|
25.11
|
USD 125,555
|
|
|
2025-04-15 |
2025-04-14 |
PS
Planned sale
|
Akinsanya Karen
President of R&D, Therapeutics
Officer
|
8,378
-25.9%
25.11
USD 210,391
|
8,378
-25.9%
|
25.11
|
USD 210,391
|
|
|
2025-03-07 |
2025-03-06 |
PS
Planned sale
|
Herman Jenny
SVP & Controller
Officer
|
666
-2.4%
21.11
USD 14,059
|
666
-2.4%
|
21.11
|
USD 14,059
|
|
|
2025-03-04 |
2025-03-03 |
PS
Planned sale
|
Porges Geoffrey Craig
EVP & CFO
Officer
|
5,491
-16.6%
21.76
USD 119,484
|
5,491
-16.6%
|
21.76
|
USD 119,484
|
|
|
2025-02-19 |
2025-02-18 |
PS
Planned sale
|
Tran Yvonne
EVP, CLO & CPO
Officer
|
3,902
-25.9%
28.00
USD 109,256
|
3,902
-25.9%
|
28.00
|
USD 109,256
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Lorton Kenneth Patrick
EVP, CTO & COO, Software
Officer
|
985
-2.3%
24.43
USD 24,064
|
985
-2.3%
|
24.43
|
USD 24,064
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Tran Yvonne
EVP, CLO & CPO
Officer
|
828
-6.9%
24.43
USD 20,228
|
828
-6.9%
|
24.43
|
USD 20,228
|
|
|
2025-02-12 |
2025-02-11 |
PS
Planned sale
|
Herman Jenny
SVP & Controller
Officer
|
859
-4.5%
24.43
USD 20,985
|
859
-4.5%
|
24.43
|
USD 20,985
|
|
|
2025-02-12 |
2025-02-10 |
PS
Planned sale
|
Abel Robert Lorne
See Remarks
Officer
|
1,225
-13.1%
25.99
USD 31,838
|
1,225
-13.1%
|
25.99
|
USD 31,838
|
|
|
2024-10-16 |
2024-10-15 |
PS
Planned sale
|
Dugan Margaret
Chief Medical Officer
Officer
|
1,531
-10.2%
17.78
USD 27,226
|
1,531
-10.2%
|
17.78
|
USD 27,226
|
|
|
2024-03-05 |
2024-03-04 |
PS
Planned sale
|
Porges Geoffrey Craig
EVP & CFO
Officer
|
3,315
-36.8%
26.35
USD 87,360
|
3,315
-36.8%
|
26.35
|
USD 87,360
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Lorton Kenneth Patrick
EVP, CTO & COO, Software
Officer
|
901
-2.4%
28.29
USD 25,489
|
901
-2.4%
|
28.29
|
USD 25,489
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Tran Yvonne
EVP, CLO & CPO
Officer
|
758
-6.0%
28.29
USD 21,444
|
758
-6.0%
|
28.29
|
USD 21,444
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Abel Robert Lorne
See Remarks
Officer
|
1,205
-11.4%
27.55
USD 33,198
|
1,205
-11.4%
|
27.55
|
USD 33,198
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Herman Jenny
SVP & Controller
Officer
|
787
-6.3%
28.29
USD 22,264
|
787
-6.3%
|
28.29
|
USD 22,264
|
|
|
2023-08-10 |
2023-08-09 |
PS
Planned sale
|
Lorton Kenneth Patrick
EVP & Chief Technology Officer
Officer
|
10,000
-21.1%
40.06
USD 400,642
|
10,000
-21.1%
|
40.06
|
USD 400,642
|
|
|
2023-07-03 |
2023-06-30 |
PS
Planned sale
|
Tran Yvonne
EVP, CLO & CPO
Officer
|
12,040
-48.6%
50.00
USD 602,000
|
12,040
-48.6%
|
50.00
|
USD 602,000
|
|
|
2023-05-24 |
2023-05-23 |
PS
Planned sale
|
Tran Yvonne
EVP, CLO & CPO
Officer
|
7,960
-38.5%
40.01
USD 318,461
|
7,960
-38.5%
|
40.01
|
USD 318,461
|
|
|
2023-05-24 |
2023-05-23 |
PS
Planned sale
|
Lorton Kenneth Patrick
EVP & Chief Technology Officer
Officer
|
10,000
-17.4%
40.06
USD 400,587
|
10,000
-17.4%
|
40.06
|
USD 400,587
|
|
